3BIGS
3BIGS is a South Korean bioinformatics and AI company (founded 2017, Hwasong) using big data for genomics research, drug discovery, and data-driven healthcare solutions, serving pharmaceutical and healthcare sector clients.
- Company typePrivate
- Founded2017
- HeadquartersHwasong, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
3BIGS firmographics
Firmographics- Name
- 3BIGS
- Website
- https://3bigs.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- 3BIGS is a South Korean bioinformatics and AI company (founded 2017, Hwasong) using big data for genomics research, drug discovery, and data-driven healthcare solutions, serving pharmaceutical and healthcare sector clients.
- Ownership category
- akta.pro rank
3BIGS industry classification
Industry- Product category
- Bioinformatics Software
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
Keywords
Where 3BIGS is headquartered
LocationHeadquarters
- HQ city
- Hwasong
- HQ country
- South Korea
- HQ region
- Asia
Markets served
3BIGS business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
3BIGS product offering
Product offeringCore offering
3BIGS provides AI- and big data-driven bioinformatics services and analytics for genomics research, drug discovery, and data-driven healthcare solutions. The company applies machine learning and large-scale genomic data processing to support life sciences research and pharmaceutical development pipelines for organizational clients.
Differentiator
Problem solved
Functional benefit
Products and services
- AI-driven Genomics Research Analytics
Companies that use 3BIGS
Customer profileIdeal customer profiles2 records
3BIGS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
3BIGS competitors and assessment
Company assessmentEmerging players
- Arctoris: Oxford-based techbio combining automated lab experiments with AI/ML-driven analysis for drug discovery. Comparable emerging player at the intersection of data-driven biology and AI for pharma R&D.
- Insitro: US AI-driven drug discovery company combining ML with high-throughput biology for pharma partners. Comparable to 3BIGS in using AI on biological data for therapeutics discovery, but with substantially larger funding.
Broad incumbents
- Schrödinger: US-listed computational chemistry and biology platform serving pharma R&D with molecular simulation plus a growing biotech pipeline. Comparable to 3BIGS's AI-for-drug-discovery angle but at vastly greater scale and breadth.
- Recursion Pharmaceuticals: Clinical-stage TechBio combining high-throughput biology with AI/ML to discover and develop medicines at scale. Comparable AI-meets-genomics thesis to 3BIGS but operates as a broad incumbent with pipeline assets.
Direct peers
- Syntekabio: Korean AI-bio company using supercomputing and ML for drug discovery and biomarker development. Closely comparable to 3BIGS in geography, stage, and AI-driven genomics/drug-discovery focus.
- Macrogen: Seoul-based genomics services and bioinformatics company. Closest geographic and functional peer to 3BIGS, providing sequencing, multi-omics analysis, and clinical genomics services to pharma and researchers in Korea and globally.
- Standigm: Korean AI-driven drug discovery company using proprietary AI workflows for target identification and lead optimization. Comparable to 3BIGS's drug-discovery ambitions and shares Korean ecosystem and customer base.
- SOPHiA GENETICS: Swiss-based bioinformatics platform leveraging AI on multi-modal genomics and clinical data for hospital and research customers. Comparable to 3BIGS in combining bioinformatics, AI, and multi-omics analysis services at a more mature commercial stage.
- DNAnexus: US-based cloud genomics and biomedical data platform serving pharma, clinical, and research customers. Directly comparable to 3BIGS's big-data + bioinformatics positioning for genomics R&D.
Regional players
- MedGenome: India-headquartered genomics diagnostics and research services company with multi-omics analysis for clinicians and researchers. Comparable as a regional services + bioinformatics peer outside Korea.
Market position
Customer concentration
3BIGS social profiles
Digital presence3BIGS financial estimates
Financial estimateRevenue estimate
Valuation estimate
3BIGS leadership team
Management profileNumber of profiles
Profiles4 records
3BIGS funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
3BIGS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 3BIGS
What does 3BIGS do?
3BIGS provides AI- and big data-driven bioinformatics services and analytics for genomics research, drug discovery, and data-driven healthcare solutions. The company applies machine learning and large-scale genomic data processing to support life sciences research and pharmaceutical development pipelines for organizational clients.
Is 3BIGS a public or private company?
3BIGS is a private company. It is classified as venture growth investor backed and is currently operating.
When was 3BIGS founded?
3BIGS was founded in 2017. It employs 11 to 50 people.
Where is 3BIGS based?
3BIGS is headquartered in Hwasong, South Korea, in the Asia region.
Who are 3BIGS's main competitors?
Emerging players on record are Arctoris and Insitro. Broad incumbents are Schrödinger and Recursion Pharmaceuticals. Direct peers are Syntekabio, Macrogen, Standigm, SOPHiA GENETICS and DNAnexus. MedGenome is listed as a regional player.
Does 3BIGS have an API?
No public API is recorded for 3BIGS.
What industry is 3BIGS in?
3BIGS's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 541714 and its SIC code is 8731.